Tacrolimus (FK 506), a treatment for primary sclerosing cholangitis: results of an open-label preliminary trial.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  American Journal of Gastroenterology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/J.1572-0241.1995.TB08243.XPMID 7532912PMCID PMC2982698
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Elevated Circulating Immune Complexes in Primary Sclerosing Cholangitis

  2007cited by this paper
• Current concepts. Primary sclerosing cholangitis.

  1994cited by this paper
• Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: A placebo‐controlled trial

  1992cited by this paper
• A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine.

  1991cited by this paper
• FK 506: historical perspectives.

  1991cited by this paper
• FK 506 rescue therapy for resistant rejection episodes in liver transplant recipients.

  1991cited by this paper
• Clinical small bowel or small bowel plus liver transplantation under FK 506.

  1991cited by this paper
• Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: A 30‐month pilot study

  1991cited by this paper
• FK 506 for rescue treatment of acute and chronic rejection in liver allograft recipients.

  1991cited by this paper
• FK 506: reversal of humorally mediated rejection following ABO-incompatible liver transplantation.

  1991cited by this paper
• FK 506 rescue therapy in liver transplant recipients with drug-resistant rejection.

  1991cited by this paper
• FK 506 assay past and present--characteristics of FK 506 ELISA.

  1991cited by this paper
• Use of FK 506 for treatment of chronic rejection after liver transplantation.

  1991cited by this paper
• FK 506 in clinical kidney transplantation.

  1991cited by this paper
• The syndrome of primary sclerosing cholangitis.

  1990cited by this paper
• Primary sclerosing cholangitis: the emerging role for liver transplantation.

  1990cited by this paper
• Association of primary sclerosing cholangitis with HLA-DRw52a.

  1990cited by this paper
• Advances in primary sclerosing cholangitis.

  1990cited by this paper
• Asymptomatic primary sclerosing cholangitis treated with ursodeoxycholic acid.

  1990cited by this paper
• Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis.

  1989cited by this paper
• Effect of proctocolectomy for chronic ulcerative colitis on the natural history of primary sclerosing cholangitis.

  1989cited by this paper
• Different immune mechanisms leading to autoimmunity in primary sclerosing cholangitis and autoimmune chronic active hepatitis of childhood

  1989cited by this paper
• Activation of the complement system in primary sclerosing cholangitis.

  1989cited by this paper
• Prospective trial of penicillamine in primary sclerosing cholangitis.

  1988cited by this paper
• Expression of HLA-DR antigens on bile duct epithelium in primary sclerosing cholangitis.

  1988cited by this paper
• Orthotopic Liver Transplantation for Primary Sclerosing Cholangitis

  1988cited by this paper
• Primary sclerosing cholangitis and low-dose oral pulse methotrexate therapy. Clinical and histologic response.

  1987cited by this paper
• Family Incidence of Primary Sclerosing Cholangitis Associated with Immunologic Diseases

  1987cited by this paper
• The syndrome of disappearing intrahepatic bile ducts.

  1987cited by this paper
• Cholangiocarcinoma complicating primary sclerosing cholangitis: cholangiographic appearances.

  1985cited by this paper
• Immunologic analysis of mononuclear cells in liver tissues and blood of patients with primary sclerosing cholangitis

  1985cited by this paper
• [Primary sclerosing cholangitis].

  1984cited by this paper
• Current concepts in primary sclerosing cholangitis.

  1984cited by this paper
• Association of primary sclerosing cholangitis with HLA-B8.

  1983cited by this paper
• Familial occurrence of primary sclerosing cholangitis and ulcerative colitis.

  1983cited by this paper
• Primary sclerosing cholangitis: findings on cholangiography and pancreatography.

  1983cited by this paper
• Sclerosing cholangitis in ulcerative colitis. A follow-up study.

  1982cited by this paper
• Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis

  1981cited by this paper
• Clinicopathologic features of the syndrome of primary sclerosing cholangitis.

  1980cited by this paper
• Clinicopathologic features of the syndrome of primary sclerosing cholangitis

  1980cited by this paper
• Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology.

  1980cited by this paper
• Beneficial effect of cholestyramine in sclerosing cholangitis.

  1980cited by this paper
• Endoscopic retrograde cholangiopancreatography in the diagnosis of jaundice associated with ulcerative colitis.

  1974cited by this paper
• Azathioprine in primary sclerosing cholangitif.

  1971cited by this paper
• The liver in ulcerative colitis.

  1971cited by this paper
• Azathioprine treatment in primary sclerosing cholangitis.

  1971cited by this paper
• Primary sclerosing cholangitis. Complete gross and histologic reversal after long-term steroid therapy.

  1970cited by this paper
• The liver in ulcerative colitis; treatment of pericholangitis with tetracycline.

  1959cited by this paper

• Future Treatment Options for Managing Primary Sclerosing Cholangitis and Cholestatic Pruritus.

  2025cites this paper
• Immunobiology of primary sclerosing cholangitis

  2024cites this paper
• The intestinal and biliary microbiome in autoimmune liver disease—current evidence and concepts

  2022cites this paper
• Efficacy and safety of immune-modulating therapy for primary sclerosing cholangitis: A systematic review and meta-analysis.

  2022cites this paper
• Biliary Strictures: Etiologies and Medical Management

  2021cites this paper
• Dysfunctional Immune Regulation in Autoimmune Hepatitis: From Pathogenesis to Novel Therapies

  2021cites this paper
• Assessing and managing symptom burden and quality of life in primary sclerosing cholangitis patients

  2021cites this paper
• Primary Sclerosing Cholangitis

  2020cites this paper
• An update on treatment options for primary sclerosing cholangitis

  2020cites this paper
• Emerging therapies in primary sclerosing cholangitis: pathophysiological basis and clinical opportunities

  2020cites this paper
• Review of pharmacotherapeutic treatments for primary sclerosing cholangitis.

  2019cites this paper
• Treatment of primary sclerosing cholangitis in children

  2019cites this paper
• Clinical guidelines for primary sclerosing cholangitis 2017

  2018cites this paper
• Primary Sclerosing Cholangitis, Part 1: Epidemiology, Etiopathogenesis, Clinical Features, and Treatment.

  2018cites this paper
• Posibles indicaciones del tratamiento de las enfermedades autoinmunes con tacrolimus

  2017cites this paper
• Primary sclerosing cholangitis: diagnostic and management challenges

  2017cites this paper
• Update on pharmacotherapies for cholestatic liver disease

  2016cites this paper
• Surrogate endpoints for clinical trials in primary sclerosing cholangitis: Review and results from an International PSC Study Group consensus process

  2016cites this paper
• Primary Sclerosing Cholangitis

  2016cites this paper
• Biomarkers for disease progression of primary sclerosing cholangitis

  2015cites this paper
• [Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations (Spanish version)].

  2015cites this paper
• University of Birmingham Applicability and prognostic value of histologic scoring systems in primary sclerosing cholangitis

  2015cites this paper
• Applicability and prognostic value of histologic scoring systems in primary sclerosing cholangitis.

  2015cites this paper
• A network meta-analysis of the efficacy and side effects of udca-based therapies for primary sclerosing cholangitis

  2015cites this paper
• Lebertransplantation bei primär sklerosierender Cholangitis

  2015cites this paper
• An overview of current and future therapeutic strategies for the treatment of primary sclerosing cholangitis

  2014influential citation
• A Review of the Challenges Associated with the Diagnosis and Therapy of Primary Sclerosing Cholangitis

  2014cites this paper
• Medical Management of Extraintestinal Manifestations of Ulcerative Colitis

  2014cites this paper
• Hepatobiliary Manifestations of Inflammatory Bowel Disease

  2014cites this paper
• Roux-en-Y choledochojejunostomy versus duct-to-duct biliary anastomosis in liver transplantation for primary sclerosing cholangitis: a meta-analysis.

  2013cites this paper
• Expert Review of Gastroenterology & Hepatology

  2013cites this paper
• Primary sclerosing cholangitis: a review and update on therapeutic developments

  2013cites this paper
• Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations.

  2013cites this paper
• Management of primary sclerosing cholangitis: conventions and controversies.

  2012cites this paper
• Primary sclerosing cholangitis: etiopathogenesis and clinical management.

  2012cites this paper
• Current pharmacotherapy for cholestatic liver disease

  2012cites this paper
• Antibiotics for the Treatment of Primary Sclerosing Cholangitis

  2011cites this paper
• [Primary sclerosing cholangitis: diagnosis, prognosis and treatment].

  2011cites this paper
• Pharmacological management of autoimmune hepatitis

  2011cites this paper
• Autoimmune hepatitis

  2011cites this paper
• Systematic review: management options for primary sclerosing cholangitis and its variant forms – IgG4‐associated cholangitis and overlap with autoimmune hepatitis

  2011cites this paper
• Deciphering the genetic predisposition to primary sclerosing cholangitis.

  2011cites this paper
• New Treatment Strategies for Primary Sclerosing Cholangitis

  2011cites this paper
• Therapy of Dermatologic, Renal, Cardiovascular, Pulmonary, Gynecologic, Gastro-enterologic, Urologic and Fibromyalgia Manifestations Including Special Considerations at the Time of Surgery

  2011cites this paper
• Colangitis esclerosante primaria: diagnóstico, pronóstico y tratamiento

  2011cites this paper
• Deciphering the Genetic Predisposition to Primary Sclerosing Cholangitis

  2011cites this paper
• The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations.

  2010cites this paper
• 34. Primary Sclerosing Cholangitis

  2010cites this paper
• Sclerosing Cholangitis and Recurrent Pyogenic Cholangitis

  2010cites this paper
• Treatment options for primary sclerosing cholangitis

  2010cites this paper
• High‐dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

  2009cites this paper
• Minocycline in the Treatment of Patients With Primary Sclerosing Cholangitis: Results of a Pilot Study

  2009cites this paper
• Jaundice and malaise in a middle aged man

  2009cites this paper
• Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease.

  2008cites this paper
• Primary Sclerosing Cholangitis

  2008cites this paper
• Chapter 14 Primary Sclerosing Cholangitis

  2008cites this paper
• European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis.

  2008cites this paper
• Role of methotrexate in the treatment of chronic cholestatic disorders.

  2008cites this paper
• Current diagnosis and management of primary sclerosing cholangitis

  2008cites this paper
• Primary sclerosing cholangitis.

  2008cites this paper
• Clinical features and management of primary sclerosing cholangitis.

  2008cites this paper
• Endoscopy in the management of primary sclerosing cholangitis

  2008cites this paper
• Primary sclerosing cholangitis.

  2008cites this paper
• European evidence-based Consensus on the management of ulcerative colitis: Special situations.

  2008cites this paper
• High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

  2007cites this paper
• Alopecia Areata, Primary Sclerosing Cholangitis, and Ulcerative Colitis: Autoimmunity and Apoptosis as Common Links?

  2007cites this paper
• A case of juvenile advanced liver cirrhosis due to primary sclerosing cholangitis diagnosed on a gastric varices rupture

  2007cites this paper
• Tacrolimus for the treatment of primary sclerosing cholangitis

  2007influential citation
• Topical tacrolimus in the treatment of perianal Crohn's disease: Exploratory randomized controlled trial

  2007cites this paper
• Primary Sclerosing Cholangitis

  2007cites this paper
• Current treatments of primary sclerosing cholangitis.

  2007cites this paper
• Medium‐term results of oral tacrolimus treatment in refractory inflammatory bowel disease

  2007cites this paper
• The use of tacrolimus in the treatment of inflammatory bowel disease

  2007cites this paper
• European evidence based consensus on the diagnosis and management of Crohn’s disease: special situations

  2006cites this paper
• The Role of Tacrolimus in Inflammatory Bowel Disease: A Systematic Review

  2006cites this paper
• special situations diagnosis and management of Crohn's disease: European evidence based consensus on the

  2006cites this paper
• Management Of Primary Sclerosing Cholangitis.

  2006cites this paper
• Bezafibrate may attenuate biliary damage associated with chronic liver diseases accompanied by high serum biliary enzyme levels

  2006cites this paper
• The Medical Management of Primary Sclerosing Cholangitis

  2006cites this paper
• Primary sclerosing cholangitis: Diagnosis and management

  2006cites this paper
• Revisiting the immunomodulators tacrolimus, methotrexate, and mycophenolate mofetil: Their mechanisms of action and role in the treatment of IBD

  2006cites this paper
• Primary sclerosing cholangitis: Summary of a workshop

  2006cites this paper
• Basic immunosuppressive drugs outside solid organ transplantation

  2006cites this paper
• The medical management of primary sclerosing cholangitis.

  2006cites this paper
• Primary sclerosing cholangitis: updates in diagnosis and therapy.

  2005cites this paper
• Long‐term Oral Tacrolimus Therapy in Refractory to Infliximab Fistulizing Crohn's Disease.: A Pilot Study

  2005cites this paper
• Indications for non-transplant surgery in primary sclerosing cholangitis.

  2005cites this paper
• Extraintestinal Manifestations of Crohn’s Disease

  2005cites this paper
• Successful treatment of pruritus with topical tacrolimus in a patient with primary biliary cirrhosis

  2005cites this paper
• Extraintestinal Manifestations of Crohn’s Disease

  2005cites this paper
• Review article: current management of primary sclerosing cholangitis

  2005cites this paper
• Novel approaches to the treatment of primary sclerosing cholangitis

  2005cites this paper
• [Primary sclerosing cholangitis].

  2004cites this paper
• A prospective, randomized‐controlled pilot study of ursodeoxycholic acid combined with mycophenolate mofetil in the treatment of primary sclerosing cholangitis

  2004cites this paper
• Primary sclerosing cholangitis.

  2004cites this paper
• Current management of primary biliary cirrhosis and primary sclerosing cholangitis.

  2003cites this paper
• The management of primary sclerosing cholangitis

  2003cites this paper
• Treatment options for primary biliary cirrhosis and primary sclerosing cholangitis

  2003cites this paper
• Immunodulation with tacrolimus (FK506): results of a prospective, open-label, non-controlled trial in patients with inflammatory bowel disease.

  2003cites this paper
• Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation

  2003cites this paper